title: Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions.
abstract: We reported earlier (S. Singh, N. P. Shanker Narayan, P. J. Jenner, G. Ramu, M. J. Colston, H. K. Prasad, and I. Nath, Infect. Immun. 62:86-90, 1994) that polyclonal antibodies directed against selective sequences in the Mycobacterium leprae recombinant protein designated LSR were present in lepromatous leprosy patients undergoing erythema nodosum leprosum (ENL) reactions (type 2 reactions). In this study using peptides with single-residue deletions from positions 6 to 24, we define three distinct regions, GVTY, NAA, and RGD, which were important for antibody recognition and for the discrimination of clinically silent and active ENL reactions. Antibodies against NAA were found only in patients undergoing active reactions. This is in contrast to the results for the RGD motif, which was recognized in all ENL patients, irrespective of the clinical status. Though GVTY was recognized in both groups of patients, its recognition was masked by the flanking glutamic acid. These findings point towards a specific molecular recognition pattern that emerges when a lepromatous leprosy patient undergoes immune perturbations leading to ENL reactions. Moreover, the fine specificity of immunological recognition changes during the natural evolution of the host-parasite interaction.
authors.affiliation: Department of Biotechnology, All India Institute of Medical Sciences, New Delhi.
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: P J
authors.initials: PJ
authors.lastname: Jenner
authors.forename: N P
authors.initials: NP
authors.lastname: Narayan
authors.forename: G
authors.initials: G
authors.lastname: Ramu
authors.forename: M J
authors.initials: MJ
authors.lastname: Colston
authors.forename: H K
authors.initials: HK
authors.lastname: Prasad
authors.forename: I
authors.initials: I
authors.lastname: Nath
mesh_terms: D000595:Amino Acid Sequence; D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D001426:Bacterial Proteins / Q000276:immunology*; D018604:Epitope Mapping; D000939:Epitopes / Q000276:immunology; D004893:Erythema Nodosum / Q000276:immunology*; D006801:Humans; D015440:Leprosy, Lepromatous / Q000276:immunology*; D008969:Molecular Sequence Data; D009166:Mycobacterium leprae / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D000939:Epitopes; C084997:LSR2 protein, Mycobacterium leprae; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins